This is supported by our data showing that supplementation of glucose reduced inflammasome activation and IL-1β production in response to C. albicans. How these metabolic approaches to infection control could be combined with strategies targeting NLRP3 [43] is an exciting question for future studies. This evidence concerns the gene IL1B and infection.